Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Elizabeth Molina Kuna

Concepts (72)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Squamous Cell
1
2022
4
0.760
Why?
Laryngeal Neoplasms
1
2022
36
0.740
Why?
Head and Neck Neoplasms
1
2022
563
0.520
Why?
Healthcare Disparities
2
2026
733
0.440
Why?
Health Status Disparities
1
2026
322
0.370
Why?
Central Nervous System Neoplasms
2
2026
177
0.370
Why?
Triple Negative Breast Neoplasms
2
2023
220
0.290
Why?
Emergency Medical Services
1
2026
680
0.290
Why?
SEER Program
3
2026
233
0.270
Why?
Stroke
1
2026
1287
0.250
Why?
Medicare
5
2023
920
0.240
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1998
0.230
Why?
Health Resources
1
2026
131
0.220
Why?
Neoplasm Staging
3
2023
1488
0.210
Why?
Carcinoma, Small Cell
1
2024
172
0.200
Why?
Penile Neoplasms
1
2023
7
0.200
Why?
Wilms Tumor
1
2024
91
0.190
Why?
Neoplasm Invasiveness
1
2024
504
0.180
Why?
Cisplatin
1
2024
347
0.180
Why?
Costs and Cost Analysis
1
2022
217
0.180
Why?
United States
8
2026
16136
0.170
Why?
Retrospective Studies
8
2026
17438
0.170
Why?
Urinary Bladder Neoplasms
1
2024
259
0.160
Why?
Neoadjuvant Therapy
1
2024
475
0.160
Why?
Skilled Nursing Facilities
1
2022
152
0.150
Why?
Hospice Care
1
2023
230
0.150
Why?
Kidney Neoplasms
1
2024
419
0.150
Why?
Breast Neoplasms
2
2023
2418
0.150
Why?
Health Services Accessibility
1
2026
1107
0.130
Why?
Patient Discharge
3
2026
997
0.130
Why?
Prostatic Neoplasms
1
2024
972
0.130
Why?
Chemotherapy, Adjuvant
3
2024
429
0.130
Why?
Neoplasms
2
2023
2954
0.120
Why?
Aged
6
2026
26432
0.120
Why?
Treatment Outcome
2
2026
11821
0.110
Why?
Anthracyclines
2
2023
49
0.090
Why?
Taxoids
2
2023
115
0.090
Why?
Subacute Care
2
2023
85
0.090
Why?
Humans
12
2026
146342
0.080
Why?
Sex Factors
1
2026
2107
0.080
Why?
Aged, 80 and over
2
2026
8391
0.070
Why?
Registries
1
2026
2400
0.060
Why?
Patient Readmission
2
2023
778
0.060
Why?
Risk Assessment
1
2026
3712
0.060
Why?
Time Factors
1
2026
7109
0.050
Why?
Prognosis
2
2024
4351
0.050
Why?
Vinblastine
1
2024
75
0.050
Why?
Cystectomy
1
2024
46
0.050
Why?
Bridged-Ring Compounds
1
2023
31
0.050
Why?
Biology
1
2024
90
0.050
Why?
Methotrexate
1
2024
234
0.050
Why?
Deoxycytidine
1
2024
219
0.050
Why?
Death
1
2023
129
0.040
Why?
Risk Factors
1
2026
10921
0.040
Why?
Doxorubicin
1
2024
416
0.040
Why?
Rural Population
1
2026
677
0.040
Why?
Cause of Death
1
2023
456
0.040
Why?
Male
4
2026
73396
0.040
Why?
Infant
2
2026
10114
0.040
Why?
Child
3
2026
22693
0.040
Why?
Female
4
2026
79499
0.040
Why?
Social Determinants of Health
1
2024
317
0.040
Why?
Middle Aged
2
2026
36619
0.040
Why?
Kaplan-Meier Estimate
1
2021
970
0.040
Why?
Databases, Factual
1
2024
1493
0.030
Why?
Activities of Daily Living
1
2022
442
0.030
Why?
Case-Control Studies
1
2023
3647
0.030
Why?
Adolescent
2
2026
22557
0.030
Why?
Hospitalization
1
2023
2475
0.020
Why?
Child, Preschool
1
2026
11913
0.020
Why?
Prospective Studies
1
2023
8123
0.020
Why?
Adult
1
2023
41087
0.010
Why?
Molina Kuna's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)